Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Adjunctive aerosolized colistin for multi-drug resistant gram-negative pneumonia in the critically ill: a retrospective study.

Doshi NM, Cook CH, Mount KL, Stawicki SP, Frazee EN, Personett HA, Schramm GE, Arnold HM, Murphy CV.

BMC Anesthesiol. 2013 Nov 25;13(1):45. doi: 10.1186/1471-2253-13-45.

2.

Bleeding risk factors associated with argatroban therapy in the critically ill.

Doepker B, Mount KL, Ryder LJ, Gerlach AT, Murphy CV, Philips GS.

J Thromb Thrombolysis. 2012 Nov;34(4):491-8. doi: 10.1007/s11239-012-0758-y.

PMID:
22743780
3.

Nephrotoxicity associated with intravenous colistin in critically ill patients.

Doshi NM, Mount KL, Murphy CV.

Pharmacotherapy. 2011 Dec;31(12):1257-64. doi: 10.1592/phco.31.12.1257.

PMID:
22122186
4.

Haemophilus ducreyi SapA contributes to cathelicidin resistance and virulence in humans.

Mount KL, Townsend CA, Rinker SD, Gu X, Fortney KR, Zwickl BW, Janowicz DM, Spinola SM, Katz BP, Bauer ME.

Infect Immun. 2010 Mar;78(3):1176-84. doi: 10.1128/IAI.01014-09. Epub 2010 Jan 19.

5.

Haemophilus ducreyi is resistant to human antimicrobial peptides.

Mount KL, Townsend CA, Bauer ME.

Antimicrob Agents Chemother. 2007 Sep;51(9):3391-3. Epub 2007 Jul 9.

Supplemental Content

Loading ...
Support Center